Physician profile
Ragda Hindi
NPI 1316565609
$949.09
in general payments reported to CMS, 2019-2025
8 companies · $300 in 2025
The $300 reported for 2025 was more than what 83% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.03 · 2021: $32.59 · 2022: $160 · 2023: $208 · 2024: $235 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $374.84 | 2022-2025 | Invisalign, Invisalign Go |
| Zimvie INC. | $227.25 | 2023-2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $158.33 | 2020-2025 | Arestin, Ossix Plus |
| Dentsply Sirona INC | $76.23 | 2023-2025 | Tph Spectra Universal Composite Restorative Low Viscosity, Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive, Midwest |
| Septodont INC. | $54.29 | 2025 | Bioroot Flow Sample |
| Straumann USA LLC | $32.47 | 2024 | |
| Philips North America LLC | $14.59 | 2023 | |
| Ultradent Products INC | $11.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ragda Hindi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.